Tempus AI
AI-powered precision medicine and genomic testing built on the world's largest library of clinical and molecular data.
Overview
Tempus AI stands out because it's not just a software vendor pitching an AI feature — it's a real diagnostics company with FDA-cleared tests, a public listing, and deep partnerships across oncology and biopharma. For hospital systems and pharma companies looking to combine genomic data with AI-driven treatment insights, Tempus offers a scale of data and clinical validation that's hard to match. It's a genuinely useful entry for readers interested in how AI is actually changing patient care, not just chatbots.
The tradeoff is that this isn't a tool an individual reader can sign up for and try — it's sold to health systems, labs, and pharma companies through enterprise contracts, with pricing negotiated case by case. Readers evaluating it should think of it as an institutional decision rather than a personal software purchase, and should compare it against other precision oncology platforms (like Foundation Medicine or Guardant Health) when relevant.
Key Features
Genomic Sequencing: FDA-approved tumor-only sequencing (xT CDx) and an upcoming whole-genome test (xH) for hematologic malignancies.
Multimodal Data Library: One of the largest libraries of clinical and molecular data, used to train AI models that surface treatment-relevant insights.
Clinical Decision Support: AI tools that help physicians match patients to therapies and clinical trials based on their molecular profile.
Drug Discovery Support: Data and analytics products that help biopharma partners accelerate discovery and development of new therapeutics.
Health System Integration: Built to plug into hospital and lab workflows so oncology teams get results inside existing systems.
Pricing
Starting price
Custom/enterprise pricing only, contact sales
Enterprise/Institutional: Pricing is fully custom and negotiated directly with health systems, labs, and biopharma partners; no published rate card exists.
Disclaimer: pricing may change, confirm on Tempus AI's own site or by contacting their sales team before buying.
Pros
Massive Data Moat: One of the largest multimodal clinical and molecular datasets in precision medicine, which strengthens its AI models over time.
Regulatory Credibility: FDA-approved diagnostic products, not just experimental AI features.
Public Company Transparency: As a NASDAQ-listed company (TEM), financials and strategy are publicly reported, adding a layer of accountability.
Broad Ecosystem: Serves both clinical care (physicians) and drug development (biopharma), extending its impact across the healthcare pipeline.
Cons
No Self-Serve Access: There's no way for an individual or small clinic to just sign up; everything runs through enterprise/institutional sales.
Opaque Pricing: No public pricing information is available anywhere on their site or in press materials.
Complex Onboarding: Integrating genomic testing and AI decision support into a hospital's workflow is a significant institutional undertaking, not a quick setup.
What Makes It Unique
Unique Angle: Tempus uniquely pairs its own genomic sequencing lab with a large-scale AI data platform, letting it generate proprietary data and apply AI to it in-house, rather than relying on third-party datasets.
Kay Score
7.8
/ 10
